1787. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
Ock CY, Keam BS, Lim Y, Kim TM, Lee SH, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.
Head Neck. 2016 Feb;38(2):277-84. doi: 10.1002/hed.23891. Epub 2015 Jun 18.Link
1786. Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era.
Ha H, Keam BS, Kim TM, Jeon YK, Lee SH, Kim DW, Kim CW, Heo DS.
Cancer Res Treat. 2016 Jan;48(1):304-11. doi: 10.4143/crt.2014.339. Epub 2015 Apr 9.Link
1785. Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients.
Beom SH, Kim DW, Sim SH, Keam B, Park JH, Lee JO, Kim TM, Lee SH, Heo DS.
Cancer Res Treat. 2016 Jan;48(1):88-97. doi: 10.4143/crt.2014.201. Epub 2015 Mar 3.Link
1784. The effect of late-phase contrast enhancement on semi-automatic software measurements of CT attenuation and volume of part-solid nodules in lung adenocarcinomas.
Cohen JG, Goo JM, Yoo RE, Park SB, van Ginneken B, Ferretti GR, Lee CH, Park CM
1778. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.
Kang HJ, Hong KT, Lee JW, Kim H, Park KD, Shin HY, Lee SH, Yoo KH, Sung KW, …..Lee JH, Park JA, Park SK, Ahn HS; Korean Society of Pediatric Hematology-Oncology.